INS and type 2 diabetes mellitus: Whole genome sequencing and genome-wide association studies have identified thousands of genetic variants from T2D patients, some of which are associated with insulin sensitivity and secretion [4,5], suggesting that identification of genetic heterogeneity is a crucial step in the diagnosis, prevention, and therapy of T2D etiologies.